CCA
STLN

Castle Creek Arbitrage’s Starling Oncology STLN Stock Holding History

Castle Creek Arbitrage’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-163,847
Closed -$1.63M – 708
2021
Q3 		$1.63M Hold
163,847
– – 0.09% 224
2021
Q2 		$1.62M Hold
163,847
– – 0.09% 239
2021
Q1 		$1.63M Hold
163,847
– – 0.1% 225
2020
Q4 		$1.77M Buy
163,847
+88,000
+116% +$906K 0.11% 139
2020
Q3 		$779K Buy
+75,847
New +$788K 0.06% 102

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Castle Creek Arbitrage's STLN Position: Q4 2021 in Review

Castle Creek Arbitrage sold out of Starling Oncology (STLN) in Q4 2021, closing a stake of 163,847 shares — an estimated $1.63M sold.

Castle Creek Arbitrage first reported a position in STLN in Q3 2020 and held it in 5 quarters. The position peaked at $1.77M in Q4 2020. 21 funds tracked by Wall St. Rank hold STLN as of Q4 2021.

  • Castle Creek Arbitrage reported no remaining Starling Oncology position as of Q4 2021 after selling out during the quarter.
  • Castle Creek Arbitrage sold 163,847 Starling Oncology shares in Q4 2021, an estimated $1.63M.
  • Castle Creek Arbitrage first reported a position in Starling Oncology in Q3 2020 and held it in 5 quarters.
  • Castle Creek Arbitrage's Starling Oncology position peaked at $1.77M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Starling Oncology as of Q4 2021.

Based on Castle Creek Arbitrage's 13F filing for Q4 2021, filed 14 Feb 2022.